Annual short term debt:
$2.95B-$635.98M(-17.75%)Summary
- As of today (May 19, 2025), GSK annual short term debt is $2.95 billion, with the most recent change of -$635.98 million (-17.75%) on December 31, 2024.
- During the last 3 years, GSK annual short term debt has fallen by -$1.91 billion (-39.35%).
- GSK annual short term debt is now -67.51% below its all-time high of $9.07 billion, reached on December 31, 2019.
Performance
GSK Short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly short term debt:
$2.53B-$414.42M(-14.06%)Summary
- As of today (May 19, 2025), GSK quarterly short term debt is $2.53 billion, with the most recent change of -$414.42 million (-14.06%) on March 31, 2025.
- Over the past year, GSK quarterly short term debt has dropped by -$769.62 million (-23.30%).
- GSK quarterly short term debt is now -80.30% below its all-time high of $12.86 billion, reached on June 30, 2019.
Performance
GSK quarterly short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Short term debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
GSK Short term debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.8% | -23.3% |
| 3 y3 years | -39.4% | -53.0% |
| 5 y5 years | -67.5% | -71.8% |
GSK Short term debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -39.4% | at low | -66.1% | at low |
| 5 y | 5-year | -67.5% | at low | -71.8% | at low |
| alltime | all time | -67.5% | +1716.8% | -80.3% | +1461.4% |
GSK Short term debt History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $2.53B(-14.1%) |
| Dec 2024 | $2.95B(-17.7%) | $2.95B(-21.8%) |
| Sep 2024 | - | $3.77B(-11.5%) |
| Jun 2024 | - | $4.26B(+28.9%) |
| Mar 2024 | - | $3.30B(-7.8%) |
| Dec 2023 | $3.58B(-25.1%) | $3.58B(-39.4%) |
| Sep 2023 | - | $5.91B(-20.9%) |
| Jun 2023 | - | $7.47B(+41.5%) |
| Mar 2023 | - | $5.28B(+10.3%) |
| Dec 2022 | $4.78B(-1.6%) | $4.78B(+53.3%) |
| Sep 2022 | - | $3.12B(-22.7%) |
| Jun 2022 | - | $4.04B(-25.1%) |
| Mar 2022 | - | $5.39B(+10.9%) |
| Dec 2021 | $4.86B(-4.3%) | $4.86B(-25.7%) |
| Sep 2021 | - | $6.54B(-6.3%) |
| Jun 2021 | - | $6.98B(+60.0%) |
| Mar 2021 | - | $4.36B(-14.1%) |
| Dec 2020 | $5.08B(-44.0%) | $5.08B(-19.7%) |
| Sep 2020 | - | $6.32B(-13.9%) |
| Jun 2020 | - | $7.34B(-18.3%) |
| Mar 2020 | - | $8.99B(-0.9%) |
| Dec 2019 | $9.07B(+23.4%) | $9.07B(-10.2%) |
| Sep 2019 | - | $10.10B(-21.5%) |
| Jun 2019 | - | $12.86B(+17.2%) |
| Mar 2019 | - | $10.97B(+49.3%) |
| Dec 2018 | $7.35B(+92.5%) | $7.35B(+94.4%) |
| Sep 2018 | - | $3.78B(-16.7%) |
| Jun 2018 | - | $4.54B(-6.0%) |
| Mar 2018 | - | $4.82B(+26.4%) |
| Dec 2017 | $3.82B(-24.7%) | $3.82B(-40.0%) |
| Sep 2017 | - | $6.37B(-26.0%) |
| Jun 2017 | - | $8.60B(+84.3%) |
| Mar 2017 | - | $4.67B(-8.0%) |
| Dec 2016 | $5.07B(+161.8%) | $5.07B(-1.2%) |
| Sep 2016 | - | $5.13B(-15.0%) |
| Jun 2016 | - | $6.04B(+240.7%) |
| Mar 2016 | - | $1.77B(-8.6%) |
| Dec 2015 | $1.94B(-57.7%) | $1.94B(-10.1%) |
| Sep 2015 | - | $2.15B(-44.6%) |
| Jun 2015 | - | $3.89B(-19.0%) |
| Mar 2015 | - | $4.80B(+4.7%) |
| Dec 2014 | $4.58B(-0.4%) | $4.58B(-47.2%) |
| Sep 2014 | - | $8.67B(+62.0%) |
| Jun 2014 | - | $5.35B(+73.2%) |
| Mar 2014 | - | $3.09B(-32.8%) |
| Dec 2013 | $4.60B(-21.6%) | $4.60B(+3.4%) |
| Sep 2013 | - | $4.45B(+25.0%) |
| Jun 2013 | - | $3.56B(+15.8%) |
| Mar 2013 | - | $3.07B(-47.6%) |
| Dec 2012 | $5.87B(+41.1%) | $5.87B(-13.0%) |
| Sep 2012 | - | $6.74B(+18.8%) |
| Jun 2012 | - | $5.67B(+30.6%) |
| Mar 2012 | - | $4.34B(+4.5%) |
| Dec 2011 | $4.16B(+825.6%) | $4.16B(+205.7%) |
| Sep 2011 | - | $1.36B(-18.6%) |
| Jun 2011 | - | $1.67B(+302.8%) |
| Mar 2011 | - | $414.61M(-7.7%) |
| Dec 2010 | $449.13M | $449.13M(-26.3%) |
| Sep 2010 | - | $609.61M(-9.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | $676.87M(-56.9%) |
| Mar 2010 | - | $1.57B(-34.0%) |
| Dec 2009 | $2.38B(+69.9%) | $2.38B(-21.2%) |
| Sep 2009 | - | $3.02B(+54.7%) |
| Jun 2009 | - | $1.95B(+6.6%) |
| Mar 2009 | - | $1.83B(+30.7%) |
| Dec 2008 | $1.40B(-79.9%) | $1.40B(-43.3%) |
| Sep 2008 | - | $2.47B(+7.2%) |
| Jun 2008 | - | $2.31B(-35.4%) |
| Mar 2008 | - | $3.57B(-48.8%) |
| Dec 2007 | $6.97B(+395.7%) | $6.97B(+70.9%) |
| Sep 2007 | - | $4.08B(+72.8%) |
| Jun 2007 | - | $2.36B(-0.5%) |
| Mar 2007 | - | $2.37B(+68.7%) |
| Dec 2006 | $1.41B(-61.0%) | $1.41B(+15.0%) |
| Sep 2006 | - | $1.22B(+19.0%) |
| Jun 2006 | - | $1.03B(-31.5%) |
| Mar 2006 | - | $1.50B(-58.4%) |
| Dec 2005 | $3.60B(+18.7%) | $3.60B(+26.3%) |
| Sep 2005 | - | $2.85B(-6.8%) |
| Jun 2005 | - | $3.06B(-4.0%) |
| Mar 2005 | - | $3.18B(+4.9%) |
| Dec 2004 | $3.03B(+17.1%) | $3.03B(+44.7%) |
| Sep 2004 | - | $2.10B(+5.1%) |
| Jun 2004 | - | $1.99B(-22.4%) |
| Mar 2004 | - | $2.57B(-0.9%) |
| Dec 2003 | $2.59B(+3.7%) | $2.59B(-2.3%) |
| Sep 2003 | - | $2.65B(+17.3%) |
| Jun 2003 | - | $2.26B(+8.1%) |
| Mar 2003 | - | $2.09B(-16.3%) |
| Dec 2002 | $2.50B(-18.9%) | $2.50B(-8.8%) |
| Sep 2002 | - | $2.74B(-29.2%) |
| Jun 2002 | - | $3.88B(+32.8%) |
| Mar 2002 | - | $2.92B(-5.3%) |
| Dec 2001 | $3.08B(-9.3%) | $3.08B(+11.0%) |
| Sep 2001 | - | $2.78B(-0.4%) |
| Jun 2001 | - | $2.79B(-16.9%) |
| Mar 2001 | - | $3.36B(-1.3%) |
| Dec 2000 | $3.40B(-6.5%) | $3.40B(-24.1%) |
| Sep 2000 | - | $4.48B(-4.4%) |
| Jun 2000 | - | $4.69B(-2.7%) |
| Mar 2000 | - | $4.82B(+32.5%) |
| Dec 1999 | $3.64B(+66.9%) | $3.64B(+17.7%) |
| Jun 1999 | - | $3.09B(+41.9%) |
| Dec 1998 | $2.18B(+11.4%) | $2.18B(+4.0%) |
| Jun 1998 | - | $2.10B(+7.1%) |
| Dec 1997 | $1.96B(-25.6%) | $1.96B(-25.6%) |
| Dec 1996 | $2.63B(-43.6%) | $2.63B(+79.2%) |
| Dec 1995 | $4.66B(+217.8%) | - |
| Jun 1995 | - | $1.47B(+137.9%) |
| Jun 1995 | $1.47B(+137.9%) | - |
| Jun 1994 | $616.20M(-31.6%) | $616.20M(-31.6%) |
| Jun 1993 | $900.69M(+29.5%) | $900.69M(+29.5%) |
| Jun 1992 | $695.40M(-50.8%) | $695.40M(-50.8%) |
| Jun 1991 | $1.41B(+90.7%) | $1.41B(+90.7%) |
| Jun 1990 | $740.77M(+236.6%) | $740.77M(+236.6%) |
| Jun 1989 | $220.07M(-48.9%) | $220.07M(-48.9%) |
| Jun 1988 | $430.63M(+35.8%) | $430.63M(+35.8%) |
| Jun 1987 | $317.15M(+95.5%) | $317.15M(+95.5%) |
| Jun 1986 | $162.24M | $162.24M |
FAQ
- What is GSK annual short term debt?
- What is the all time high annual short term debt for GSK?
- What is GSK annual short term debt year-on-year change?
- What is GSK quarterly short term debt?
- What is the all time high quarterly short term debt for GSK?
- What is GSK quarterly short term debt year-on-year change?
What is GSK annual short term debt?
The current annual short term debt of GSK is $2.95B
What is the all time high annual short term debt for GSK?
GSK all-time high annual short term debt is $9.07B
What is GSK annual short term debt year-on-year change?
Over the past year, GSK annual short term debt has changed by -$635.98M (-17.75%)
What is GSK quarterly short term debt?
The current quarterly short term debt of GSK is $2.53B
What is the all time high quarterly short term debt for GSK?
GSK all-time high quarterly short term debt is $12.86B
What is GSK quarterly short term debt year-on-year change?
Over the past year, GSK quarterly short term debt has changed by -$769.62M (-23.30%)